Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder’s turnaround shows up in results and guidance: Q4 adjusted EPS of $0.39 vs $0.32 estimate, with FY adjusted operating margin up 320 bps to 11.2% and gross margin at 75.5%; management raised fiscal 2027 adjusted EPS guidance to $3.10–$3.35. Nike, by contrast, guided to fiscal 2027 revenue down low-to-mid single digits, and Q4 revenue slipped 1.1% YoY with NIKE Direct down 7% and Greater China down 12% (17% ex-currency), citing a one-time $986M tariff-recovery benefit. Net: the article frames Estee Lauder as “proof beats promise,” while Nike remains a longer-timeline turnaround risk; investors are buying EL after a +27.7% month move but at ~32x forward P/E.

Analysis

EL is now in the harder part of the trade: the market has stopped paying for a story and started paying for execution. In the next 1-3 months, the key variable is not whether margins improved, but whether the mix and productivity gains can sustain into the next guide without requiring extra promotion; at a premium multiple, any deceleration will hit both EPS and the valuation regime. That said, EL’s recovery is more self-funded than cyclical, so the downside from here is usually a miss on margin durability rather than a collapse in demand.

NKE is the opposite setup: headline EPS is still inflated by non-core items, while the underlying revenue base remains weak enough that channel cleanup can continue to suppress reported growth for several quarters. The second-order effect is competitive, not just company-specific: persistent Nike discounting and slower innovation cadence can shift shelf space, marketing attention, and consumer share toward DECK, ONON, and LULU, especially in performance/running. If that share shift persists through holiday and spring assortments, Nike’s own recovery path gets longer, not shorter.

Contrarian view: EL may be less cheap than it looks after a strong run, and the easy money likely came from proving the turnaround rather than from buying it now. Conversely, NKE may be less broken than the tape implies if China stabilizes and revenue stops contracting, because the stock already discounts a prolonged repair process. The market’s miss is that EL needs continued proof to hold its multiple, while NKE needs only one or two clean quarters to force a violent squeeze in expectations; the asymmetry is therefore time-based, not just valuation-based.

Key Decisions for Investors

• Long EL / short NKE for 3-6 months as a relative-quality pair: EL has the cleaner earnings revision profile, while NKE still has operating leverage working against it. Theses fails if EL’s fiscal 2027 EPS guide is cut or NKE prints two straight quarters of flat-to-positive constant-currency revenue.
• Avoid chasing EL after the recent rerate; prefer adding on a 5-8% pullback or after the next quarter confirms margin durability. If gross margin slips back below the mid-75% area or operating margin loses momentum, trim immediately.
• Use NKE rally risk to buy 6-9 month put spreads or sell call spreads rather than outright shorting. Best entry is into any relief bounce before the market gets evidence of China stabilization; the trade works if guidance remains negative and promotional pressure persists.
• Overweight DECK and ONON versus NKE on a 6-12 month basis as share-shift beneficiaries from Nike’s longer repair cycle. Falsify if Nike’s direct business reaccelerates and wholesale inventories normalize without extra discounting.
• Set a watch item on EL’s next guide revision and NKE’s China/Direct trends: EL is the higher-quality long only if guidance holds; NKE becomes investable only after revenue inflects, not on dividend yield alone.